Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Lovestone

Showing results (271-280 of 333) with videos related to

Pageof 34
Sort By:
Stem Cells (Dayton, Ohio)|December 20, 2024
Changes in iPSC-astrocyte morphology reflect Alzheimer's disease patient clinical markersHelen A Rowland, Georgina Miller, Qiang Liu, et al.
Medrxiv : the Preprint Server for Health Sciences|November 11, 2020
Cerebrospinal fluid total tau levels indicate aberrant neuronal plasticity in Alzheimer's diseasePieter Jelle Visser, Lianne M Reus, Johan Gobom, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 29, 2005
Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzymePetra Nowotny, Anthony L Hinrichs, Scott Smemo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 6, 2024
CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's diseaseAurore Delvenne, Johan Gobom, Suzanne E Schindler, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 14, 2025
Cerebrospinal fluid proteomic associations of APOE genotypes reveal distinct protective and risk mechanisms for Alzheimer's diseaseEleonora M Vromen, Senne B Lageman, Johan Gobom, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 12, 2019
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrumIsabelle Bos, Stephanie Vos, Frans Verhey, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 2004
Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene familyYonghong Li, Petra Nowotny, Peter Holmans, et al.
Fluids and Barriers of the CNS|July 17, 2024
Involvement of the choroid plexus in Alzheimer's disease pathophysiology: findings from mouse and human proteomic studiesAurore Delvenne, Charysse Vandendriessche, Johan Gobom, et al.
Molecular Neurodegeneration|March 29, 2022
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's diseasePieter Jelle Visser, Lianne M Reus, Johan Gobom, et al.
Molecular Neurodegeneration|May 13, 2022
Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's diseasePieter Jelle Visser, Lianne M Reus, Johan Gobom, et al.
Pageof 34

Showing results (271-280 of 333) with videos related to

Sort By:
Pageof 34
Stem Cells (Dayton, Ohio)|December 20, 2024
Changes in iPSC-astrocyte morphology reflect Alzheimer's disease patient clinical markersHelen A Rowland, Georgina Miller, Qiang Liu, et al.
Medrxiv : the Preprint Server for Health Sciences|November 11, 2020
Cerebrospinal fluid total tau levels indicate aberrant neuronal plasticity in Alzheimer's diseasePieter Jelle Visser, Lianne M Reus, Johan Gobom, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 29, 2005
Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzymePetra Nowotny, Anthony L Hinrichs, Scott Smemo, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 6, 2024
CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's diseaseAurore Delvenne, Johan Gobom, Suzanne E Schindler, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 14, 2025
Cerebrospinal fluid proteomic associations of APOE genotypes reveal distinct protective and risk mechanisms for Alzheimer's diseaseEleonora M Vromen, Senne B Lageman, Johan Gobom, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 12, 2019
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrumIsabelle Bos, Stephanie Vos, Frans Verhey, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 28, 2004
Association of late-onset Alzheimer's disease with genetic variation in multiple members of the GAPD gene familyYonghong Li, Petra Nowotny, Peter Holmans, et al.
Fluids and Barriers of the CNS|July 17, 2024
Involvement of the choroid plexus in Alzheimer's disease pathophysiology: findings from mouse and human proteomic studiesAurore Delvenne, Charysse Vandendriessche, Johan Gobom, et al.
Molecular Neurodegeneration|March 29, 2022
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's diseasePieter Jelle Visser, Lianne M Reus, Johan Gobom, et al.
Molecular Neurodegeneration|May 13, 2022
Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's diseasePieter Jelle Visser, Lianne M Reus, Johan Gobom, et al.
Pageof 34